Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2701
https://www.valueinhealthjournal.com/article/S1098-3015(17)33035-8/fulltext
Title : Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33035-8&doi=10.1016/j.jval.2017.08.2701
First page : A895
Section Title : SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? : No
Section Order : 2487
Categories :
Tags :
Regions :
ViH Article Tags :